Chinese universities delay fall semester

Aug 06, 2021, 15:49

A section of Chinese universities, especially those located in the cities that have medium- and high-risk areas, have delayed the fall semester scheduled to begin around September due to the surge in COVID-19 cases in some parts of the country.

Eastern China's Nanjing city reported 317 cases of COVID-19 by Wednesday. Alarmed by the outbreak, the Southeast University canceled the summer holiday starting Monday to start the fall semester, which started a month earlier.

The Nanjing University of Science and Technology asked students not to return after summer holidays, and Nanjing Tech University implemented the closed-off management of its campus.

Tsinghua University in Beijing announced that the students in the medium and high-risk areas should not return to school and delayed registration of new students. The new schedule for students will be updated.

Beijing Language and Culture University and Fudan University in Shanghai have asked their students who are residing in the medium- and high-risk areas to refrain from returning to school temporarily.

Tianjin University in north China and the Northwest A&F University in the northwest postponed the beginning of their semester as well.

source: CGTN

3 1234

Add a comment

Newtown

Fred9 post time: 2021-08-07 11:45

Obviously they are not very confident about this since the delta variant is much more susceptible for young people compared to other virus strains. Evidence of this is mounting throughout the country and abroad.

Report

Fred9

If authorities is confident of current covid-19 vaccine is effective new delta variant and other variants then delaying education is bad for students. Considering they need to graduate and join the job market workforce.

Report

markwu

Having worked so hard to successfully contain the epidemic, it is wise to prevent the delta variant from spreading more. This variant is highly transmissible and affects the young as well. Its outward symptoms include prolonged headaches, blocked or runny nose, sore throat, vomiting, diarrhoea, backaches and lethargia.

The strategy remains denying the virus from replicating itself in new hosts during its short lifespan - by vaccination to increase antibody count and reduce severity of infection effects thereby improving recovery, and also by masking, social-distancing and cluster quarantine.

On a longer term, more study should be done on how the human immune system reacts to different viruses with view to engineering a more universal and ubiqitous vaccine as fast-track interim solution to reduce the initial effects of new variants.

Report